OA16423A - Agomelatine intermediates and preparation method thereof. - Google Patents

Abstract

The present invention relates to the Intermediate compounds for preparation of agomelatine, as well as the preparation methods thereof. The intermediate of the present invention for preparation of agomelatine is compound A as shown in the following formula. Also provided are two novel intermediate compounds. When we use thse new intermediate compounds to prepare agomelatine, it is simple to manipulate, wellcontrolled and with high prity, without complicated operations such as rectification and column chromatography separation, and suitable for industrial production. Meanwhile, the preparation methods of the two new intermediates themselves is simple and high yield, only using the most commonly-used 7-methoxy-tetralone as original starting material and undergoing one step of reaction to obtain the intermediates, followed by one more step of converting the intermediate compounds to desired product agomelatine. Said reaction processes are greatly simplified, with the reaction yield being improved and the difficulty in purification of previous method being overcome, as compare with the previous technique for preparation of agomelatine. Typically, the yield of the present invention is over 70%.

Description

Field of the invention

The invention relates to intermediate compounds for préparation of agomelatine, as well as the préparation methods thereof.

Background of the invention

Agomelatine has a chemical structure as shown in Fomula (I), with the chemical name N-[2(7-methoxy-l-naphthyl)ethyl]acetamide and trade name Valdoxan. It has dual pharmacological effects, which is not only the agonist of melatonergic System receptors, but also the antagonist of 5HT2C receptor. Said properties confer activity in the centrai nervous System, especially in the treatment of major dépréssion, seasonal affective disorders, dyssomnia, cardiovascular diseases, digestive System diseases, insomnia and fatigue caused by jet lag, appetite disorders and obesity. It is the first melatonin type antidepressive agent, which can effectively treat dépressive disorders, improve the sleep parameters and maintain sexual function. It was approved by EU on Feb 24^th, 2009, with the trade name Valdoxan®/Thymanax®.

Taking into account the compound’s pharmaceutical value, it is important to obtain the compound in an effective industrial synthetic method, which can be easily converted into iargescale production in the industry and obtain agomelatine in good yield and high purity.

Many synthetic methods for agomelatine hâve been reported, which can be roughly divided into four types, in which ail of the starting materials are the compound of formula (II). European patent spécification EP0447285 reported a method for préparation of agomelatine (I): reacting 7methoxy-tetralone (II) with ethyl bromoacetate by Reformatsky reaction, and then dehydroaromatization with sulfur to obtain (7-methoxy-l-naphthyl)acetic acid ethyl ester (IV), followed by hydrolysis, acyl chlorination, ammonification, déhydration and réduction to yield the

ORIGINAL compound (VIII), which is finally acetylated to obtain agomelatine (I), as shown below:

However, there are some defects in the above method, which comprise:

(1) it takes eight steps to synthesize 2-(7-methoxy-l-naphthyl)ethylamine, thereby rendering the average yield being less than 30%;

(2) when the above method is converted into industrial scale, it is difficult to carry out the reaction, mainly due to the poor reproducibility of the first step; the first step comprises reacting 7-methoxy-tetraIone (II) with ethyl bromoacetate by Reformatsky reaction to produce ethyl (7-methoxy-3,4-dihydronaphthalen-l(2H)-ylidene)acetate, which requires benzene as the solvent; considering the envîronmental factors, said step does not meet the requirements of large-scale production; and (3) the next step for aromatization of ethyl (7-methoxy-3,4-dihydronaphthalen-l(2H)ylîdene)acetate is usually incomplète, and after saponification often results in a mixture, from which it is difficult to separate pure product (IV).

Chinese patent spécification CN1680284 reported another method for agomelatine synthesis: reaction of 7-methoxy-tetralone (II) with cyano-acetic acid produces intermediate compound (IX), the intermediate (IX) is dehydrogenated in the presence of hydrogénation

ORIGINAL S catalyst Pd-C, with allyl méthacrylate as the dehydrogenating agent, followed by réduction to generate compound (VIII), and fînally the compound (VIII) is converted to agomelatine (I) by acétylation. The total yield is about 72%, as shown below:

But there are some defects in the above method:

(l) some carcinogenic agents are used in the reaction route, for example, benzylamine/heptanoic acid catalyst System with great toxicity is used in the conversion of formula (II) to formula (IX);

(2) propyl méthacrylate is used as the dehydrogenating agent during the conversion of formula (IX) to (VII), which results in a lot of environmental pollution, moreover, this step of reaction actually was found to be low yield and difficult to reproduce; and (3) during the hydrogénation process of conversion of formula (VII) to (VIII), a by-product having formula (XII) generated; since the nature of the by-product is similar to the 15 desired product and this step is the penultimate step, it is difficult to purify the desired product and the yield loss after recrystallization is large.

JF

ORIGINAL

Considering the médicinal value and good market prospects of agomelatine, it is important to synthesize the compound of formula (I) in an effective manner for industrialization.

Disclosure of the invention

One objective of the présent invention is to provide two novel intermediate compounds for préparation of agomelatine. When we use these new compounds to préparé agomelatine, it is simple to manipulate and easy for working-up (without complicated operations such as rectification and column chromatography séparation), well-controlled, with high purity and yield, and suitable for industrial production.

Another objective of the présent invention is to provide préparation methods for the two intermediate compounds above and the use thereof.

For these purposes, the following technical solutions are used in the présent invention.

The compound of formula (A) is used:

ORIGINAL

The method for préparation of the compound of formula (A) is reductive acylation of the compound of formula (C) under the condition of catalytic hydrogénation, in the presence of acetîc anhydride.

Métal catalyst/Ac₂O

NHCOMe

The catalyst used in the conversion of the compound of formula (C) to the compound of formula (A) is conventional métal catalyst, such as activated cobalt, activated nickel (Ni), preferably Raney-Ni; the amount of catalyst can be 0.1-0.3 times the amount of the compound C by weight; the amount of acetic anhydride is l-3 times the molar amount of the compound C, more preferably 1-1.3 times. The organic solvent used in this reaction is commonly-used organic 10 solvents, such as dioxane, THF, acetonitrile or acetic anhydride, preferably THF. The optimal reaction température is 10-50 °C, more preferably 20-30 °C. The reaction time dépends on the complété consumption of reactants detected, typically is 6-12 hours. After the reaction is completed, the working-up procedure can be performed according to conventional methods in the art.

The method for préparation of agomelatine using the compound A is provided in the présent

ORIGINAL invention, comprising déhydration and aromatization of the compound A to obtain the desired product of formula I:

Dehydrogenating agent

NHCOCH3

NHCOCH3

In the conversion of the compound A to the compound I by aromatization as shown above, the 5 dehydrogenating agent is preferably dichloro-dicyanobenzoquinone (DDQ), the amount of said dehydrogenating agent is preferably l-3 times the molar amount of the compound A, more preferably 1-1.3 times. The organic solvent used in this reaction is commonly-used organic solvents, eg. one of toluene, dioxane, THF, acetonitrile or glacial acetic acid, or any mixture thereof, preferably the mixture of toluene and glacial acetic acid, the mixture of acetonitrile and IO glacial acetic acid, or glacial acetic acid. The amount of said organic solvent is generally 10-50 ml/g of the compound A. The reaction température is preferably 30-150 °C, more preferably 50l00°C. The reaction time dépends on the complété consumption of reactants detected, typically is from 30 minutes to 12 hours. After the reaction is completed, the working-up procedure can be performed according to conventional methods in the art.

ORIGINAL

The compound of formula (B) is used:

NHCOCH3

The method for préparation of the compound of formula (B) is déhydration of the compound

A under acidic condition:

Acid

NHCOCH3

NHCOCH3

The acid used in the conversion of the compound A to the compound B is a conventional acid, such as hydrohalogen acid, sulfuric acid, acetic acid, and the like. The organic solvent used is commonly-used organic solvent, such as alcohols, dioxane, THF, or acetonitrile, preferably alcohol solvent, eg., ethyl acetate, acetone and the like. The amount of said organic solvent is ÎO generally 10-50 ml/g of the compound A. The reaction température is preferably -20-40 °C,more

ORIGINAL preferably 0-30 °C. The reaction time dépends on the complété consumption of reactants detected, typically is l-3 hours. After the reaction is completed, the working-up procedure can be performed according to conventional methods in the art.

The method for préparation of agomelatine using the compound B is provided in the présent invention, comprising reaction of the compound B with a dehydrogenating agent, to obtain the desired product of formula I:

Dehydrogenating agent

In the conversion of the compound B to the compound I, the dehydrogenating agent is preferably dichloro-dicyanobenzoquinone (DDQ), the amount of said dehydrogenating agent is 10 preferably l-3 times the molar amount of the compound B, more preferably 1-1.3 times. The organic solvent used in this reaction is commonly-used organic solvents, such as dichloromethane, dioxane, THF, acetonitrile, glacial acetic acid, or the like, preferably dichloromethane or toluene. The amount of said organic solvent is generally 10-50 ml/g of the compound B. The reaction température is preferably 0-50°C, more preferably 10-30°C. The reaction time dépends on the complété consumption of reactants detected, typically is from 30 & ORIGINAL minutes to 6 hours. After the reaction is completed, the working-up procedure can be performed according to conventional methods in the art.

The method for préparation of agomelatine comprises the following steps:

a. reductive acylation of the compound C under the condition of catalytic hydrogénation and in the presence of acetic anhydride to obtain compound A

Métal catalyst/Ac₂O

NHCOMe

J

b. déhydration and aromatization of the compound A with a dehydrogenating agent, to obtain the desired product of formula I

ORIGINAL

Dehydrogenating agent

NHCOCH3

NHCOCH3

In the method for préparation of agomelatine in the présent invention, we can also use the following route, comprising firstly dehydrating compound A under acidic condition to produce compound B, then reacting compound B with a dehydrogenating agent to obtain the desired 5 product of formula I

ORIGINAL

Dehydrogenating agent

NHCOCH3

NHCOCH3

The intermediate compound of formula C can be made by the condensation of formula II and acetonitrile in the presence of catalyst

ORIGINAL

The catalyst used in the conversion of the compound of formula II to the compound of formula (C) is butyl lithium. Both the amount of catalyst and the amount of acetonitrile are l-3 times the molar amount of the compound II, more preferably 1-1.3 times. The organic solvent 5 used in this reaction is anhydrous organic solvent, such as dioxane, THF, and the like, which needs déhydration treatment or can be purchased directly from commercial suppliers. The amount of said organic solvent usually is 5-20 ml/g of the compound IL The optimal reaction température is from -80 to -50°C, more preferably from -70 to -60°C. The reaction time dépends on the complété consumption of reactants detected, typically is from 1 minute to 3 hours. After the 10 reaction is completed, the working-up procedure can be performed according to conventional methods in the art.

The compound C can also be prepared according to the methods disclosed in related literatures such as Journal of Médicinal Chemistry, 1976, 19(6), 803.

The reagents and starting materials used in the présent invention are commercially available, unless specified otherwise.

The advantages of the présent invention are:

the invention provides two novel intermediate compounds; when we use these new compounds to préparé agomeiatine, it is simple to manipulate and easy for working-up, without complicated operations such as rectification and column chromatography séparation, wellORIGINAL __ controlled, with high purity, and suitable for industrial production. Meanwhile, the préparation method of the two new intermediates themselves is simple and high yield, only using the most commonly-used 7-methoxy-tetralone (II) as original starting material and undergoing one step of reaction to obtain the intermediates, followed by one more step of converting the intermediate compounds to desired product agomelatine. Said reaction processes are greatly simplified, with the reaction yield being improved and the difficulty in purification of previous method being overcome, as compare with the previous technique for préparation of agomelatine. Typically, the yield of the présent invention is over 70%.

Examplcs

The foilowing examples are utilized for further illustration of the présent invention, but they are not intended to limit the scope of the invention in any manner.

Example 1:

1) Synthesis of 2-(l-hydroxyl-7-methoxy-l,2,3,4-tetrahydro-naphthalen-l-yl)-acetonitrile (the compound C)

To a reaction vessel was added acetonitrile (19.0 ml) and anhydrous THF (50 ml), cooled to -70°C with dry ice/ethanol, then the solution of n-Butyl Lithium in n-hexane (2.5 M, 142.0 ml) was added dropwise slowly. After stirring for half an hour under this température, the solution of the compound II (44.6 g) in anhydrous THF (300 ml) was added dropwise slowly, and stirred for 1 h at the same température. The reaction is quenched by adding saturated aqueous ammonium chloride (700 ml), extracted with ethyl acetate (350 ml x 3). The organic layers were combined, washed with saturated aqueous NaCl (350 ml), dried over anhydrous sodium sulfate, and concentrated to obtain the off-white title product (54.3 g). Yield: 98.3%.

Example 2:

2) Synthesis of N-[2-(l-hydroxyl-7-methoxy-l,2,3,4-tetrahydro-naphthalen-l-yl)ethyl]acetamide (the compound A)

The compound C (54.3 g) was dissolved in THF (500 ml), and acetic anhydride (33.1 g) and Raney-Ni (10 g) were then added. The reaction mixture was hydrogenated with the hydrogen pressure maintaining 1.1 Mpa at température 30°C, until the reaction is completed. The mixture

ORIGINAL was cooled to room température, filtered and concentrated to remove THF. The residue was diluted with ethyl acetate (500ml), washed with saturated aqueous NaHCOj (150 ml), water (150 ml) and saturated aqueous NaCl (150 ml). The resulting organic phase was dried over anhydrous sodium sulfate, filtered and concentrated to obtain the off-white product A (56.0 g). Yield: 85% ‘HNMR(CDC1₃) S: 1.77-1.98 (m, 4H), 1.92 (s, 3H), 2. 01-2.11 (m, 2H), 2. 28 (s,

0H) , 2. 67-2.77(m, 2H) , 3.28-3. 50(m, 2H), 3.80 (s, 3H), 6.32 (s, NH),

6.74-7.27 (m, 3H)_O

ESI-MS (m/z): 286.1 (M+Na).

Mp: 106-109°C.

Example 3:

3) Synthesis of N-[2-(7-methoxy-1 -naphthyl)ethyl]acetamide (the compound I)

The compound A (56.0 g) was dissolved in toluene (500 ml) and acetic acid (50 ml), DDQ (53.2g) was added, and the mixture was heated at 40°C for about 5 h. After the reaction was completed, the mixture was filtered, and the filtrate was washed with saturated aqueous NaHCCh ORIGINAL (250 ml x 2), water (250 ml) and saturated aqueous NaCl (250 ml). The resulting organic phase was dried over anhydrous sodium sulfate, filtered and the solvent was evaporated off. The residue was recrystallized from ethanol-water (1:1), dried in an oven to obtain the title product as white powder (43.8 g). Yield: 85%.

*HNMR(CDCl₃)ô: 1.922 (s, 3H), 3.21-3.24(t, 2H), 3.56-3.61(q, 2H) , 3.96(s, 3H), 5.97 (s, 1H), 7.14-7.16 (q, 1H), 7.22-7.26 (m, 2H), 7.46-7.47 (m, 1H), 7.64-7.67 (m, 1H), 7.72-7.74 (d, 1H). ESI -MS(m/z): 244.14 (M+H).

Example 4:

1) Synthesis of 2-(l-hydroxyl-7-methoxy-l,2,3,4-tetrahydro-naphthalen-l-yl)-acetonitrile (the compound C)

To a reaction vessel was added acetonitrile (9.5 ml) and anhydrous THF (25 ml), cooled to 70°C with dry ice/ethanol, and then the solution of n-Butyl Lithium in n-hexane (2.5 M, 71.0 ml) was added dropwise slowly. After stirring for half an hour under this température, the solution of the compound II (22.3 g) in anhydrous THF (150 ml) was added dropwise slowly, and stirred for 1 h at the same température. The reaction is quenched by adding saturated aqueous ammonium chloride (350 ml), extracted with ethyl acetate (200 ml x 3). The organic layers were combined, washed with saturated aqueous NaCl (200 ml), dried over anhydrous sodium sulfate, and concentrated to obtain the off-white title product (27.2 g) e. Yield: 98.4%.

Example 5 :

2) Synthesis of N-[2-(l-hydroxyl-7-methoxy-I,2,3,4-tetrahydro-naphthalen-l-yl)ethyl]acetamide (the compound A)

The compound C (27.2 g) was dissolved in THF (250 ml), and acetic anhydride (15.6 g) and Raney-Ni (4 g) were then added. The reaction mixture was hydrogenated with the hydrogen pressure maintaining 1.1 Mpa at température 30°C, until the reaction is completed. The mixture was cooled to room température, filtered and concentrated to remove THF. The residue was diluted with ethyl acetate (250 ml), washed with saturated aqueous NaHCO₃ (100 ml), water (100 ml) and saturated aqueous NaCl (100 ml). The resulting organic phase was dried over anhydrous

OR1G1NAL sodium sulfate, filtered and concentrated to obtain the off-white title product (28.0 g). Yield:

85%.

’HNMR (CDCls) 5 : 1.77-1.98 (m, 4H), 1.92 (s, 3H), 2.01-2.11 (m,2H), 2. 28 (s,

OH) , 2.67-2.77(m, 2H) , 3.28-3.50(m,2H), 3.80 (s, 3H), 6.32 (s, NH),

6.74-7.27 (m, 3H) »

ESI-MS (m/z): 286.1 (M+Na).

Mp: 106-109°C.

Example 6:

3) Synthesis of N-[2-(7-methoxy-3,4-dîhydro-naphthalen-l-yl)ethyl]acetamide (the compound B)

The compound A (28.0 g) was dissolved in ethyl acetate (300ml) to form a suspension, to 10 which concentrated HCl (12 M, 13.3 ml) was then added dropwise at RT. The suspension gradually tumed clear. The réaction solution was further stirred for 2 h and poured into water (150 ml). After the layers separated, the organic phase was washed with saturated aqueous

ORIGINAL

NaHCOî (150 ml x 2) and saturated aqueous NaCl (150 ml), dried over anhydrous sodium sulfate, filtered and concentrated to obtain the title product as oil (25.5 g). Yield: 97.8%.

^lHNMR(CDCl_s) δ : 1,944 (s, 3H), 2. 21-2. 27 (m, 2H), 2. 61-2.69 (m, 4H) ,

3.40-3.45(m,2H), 3.80 (s, 3H), 5.59 (s, NH), 5.90-5.93 (m, IH) , 6.68-7.05 (m, 3H) «

ESI -MS (m/ z) : 268. 3 (M+Na) »

Example 7:

4) Synthesis of N-[2-(7-methoxy-l-naphthyl)ethyl]acetamide (the compound I)

The compound B (25.5 g) was dissolved in dichloromethane (250 ml), DDQ (26.1 g) was added portionwîse, and the mixture was stirred overnight at RT. After the reaction was completed, the mixture was filtered, and the filtrate was washed with saturated aqueous NaHCCh (150 ml x

2), water (150 ml) and saturated aqueous NaCl (150 ml). The organic phase obtained was dried 10 over anhydrous sodium sulfate, filtered and the solvent was evaporated off. The residue was recrystallized from ethanol-water (1:1), dried in an oven to obtain white powder (46.4 g). Yield: 91.8%.

ORIGINAL ‘HNMR(CDCl₃)5: 1.922 (s_t 3H), 3.2l-3.24(t, 2H), 3.56-3.6l(q, 2H), 3.96(s, 3H), 5.97 (s, ÎH),

7.14-7.16 (q, 1H), 7.22-7.26 (m, 2H), 7.46-7.47 (m, 1H), 7.64-7.67 (m, 1H), 7.72-7.74 (d, 1H).

ESl -MS(w/z): 244.14 (M+H).

Claims (16)

1. CLAIMSi

   1. The compound A of the following formula

   NHCOMe
2. 2. The compound B of following formula:

   NHCOCH3
3. 3. A method for the préparation of the compound A of claim 1, comprising reductive acylation of the compound C under the condition of catalytic hydrogénation and in the presence of acetic anhydride

   ORIGINAL

   Métal

   NHCOMe
4. 4. The method according to claim 3, characterized in that said métal catalyst is Raney-Ni, the amount of which is 0.1-0.3 times the amount of the compound C by weight.
5. 5. The method according to claim 3, characterized in that the amount of said acetic anhydride is

   5 1-1.3 times the molar amount of the compound C.
6. 6. The method for préparation of agomelatine using the compound A, comprising déhydration and aromatization of the compound A to obtain the desired product of formula I:

   ORIGINAL

   Dehydrogenating agent

   NHCOCH3 nhcoch3
7. 7. The method for préparation of agomelatine using the compound A according to claim 6, characterized in that the dehydrogenating agent used in said aromatization îs dichlorodicyanobenzoquinone.

   5
8. 8. The method for préparation of agomelatine using the compound A according to claim 6, characterized in that the amount of dehydrogenating agent is 1-3 times the molar amount of the compound A.
9. 9. The method for préparation of agomelatine using the compound A according to claim 6, characterized in that the solvent used in the reaction is the mixture of toluene and glacial acetic
10. 10 acid, the mixture of acetonitrile and glacial acetic acid, or glacial acetic acid.

    10. A method for the préparation of the compound B of claim 2, comprising déhydration of the compound A under acidic condition:

    ORIGINAL

    Acid

    NHCOCH3

    NHCOCH3
11. 11. A method for préparation of agomelatine using the compound B, comprising reaction of the compound B with a dehydrogenating agent to obtain the desired product of formula I:

    ORIGINAL

    Dehydrogenating agent

    NHCOCH3

    NHCOCH3
12. 12. The method for préparation of agomelatine using the compound B according to claim 11, characterized in that said dehydrogenating agent is dichloro-dicyanobenzoquînone.
13. 13. The method for préparation of agomelatine using the compound B according to claim 11,

    5 characterized in that the amount of said dehydrogenating agent is 1-3 times the molar amount of the compound B.
14. 14. The method for préparation of agomelatine using the compound B according to claim 11, characterized in that the organic solvent used in the reaction is dichloromethane or toluene.
15. 15. A method for préparation of agomelatine, comprising the following steps:

    10 a. reductive acylation of the compound C under the condition of catalytic hydrogénation and in the presence of acetic anhydride to obtain compound A

    ORIGINAL

    Métal catalyst/AcîO

    N H CO Me

    b. déhydration and aromatization of the compound A with a dehydrogenating agent, to obtain the desired product of formula 1

    ORIGINAL

    Dehydrogenating agent

    NHCOCH3
16. 16. The method for préparation of agomelatine according to claim 15, characterized in firstly dehydrating the compound A under acidic condition to produce the compound B, then reacting compound B with a dehydrogenating agent to obtain the desired product of formula I _t